Bailard, Inc. Assembly Biosciences, Inc. Transaction History

Bailard, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 03, 2021	SELL	$4.87 - $17.29 $589,270 - $2.09 Million	-121,000 Closed	0 $0
Q3 2020 Nov 10, 2020	SELL	$15.08 - $27.04 $301,600 - $540,800	-20,000 Reduced 14.18%	121,000 $1.99 Million
Q2 2020 Aug 12, 2020	SELL	$14.57 - $23.96 $1.07 Million - $1.76 Million	-73,500 Reduced 34.27%	141,000 $3.29 Million
Q1 2020 Apr 16, 2020	BUY	$10.27 - $21.23 $878,085 - $1.82 Million	85,500 Added 66.28%	214,500 $3.18 Million
Q4 2019 Jan 31, 2020	BUY	$8.36 - $23.81 $1.08 Million - $3.07 Million	129,000 New	129,000 $2.64 Million

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $822M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of Bailard, Inc., based on Form 13F filings with the SEC.

Stay updated on Bailard, Inc. with notifications on news.